Global Call For Rebuilding Vaccine Networks In Advance Of COVID-19 Vaccine Rollout 24/09/2020 Raisa Santos A lineup of global health leaders called upon high income countries to join the new global COVID-19 pool, saying that worldwide access to a safe and equitable vaccine is essential to beat the COVID-19 pandemic. Speaking at the virtual UN General Assembly (UNGA) side event on Wednesday, the leaders also said that maintaining essential vaccine […] Continue reading -> COVID-19’s ‘Slow Burn’ – Africa’s Low Death Rate Puzzles Researchers 14/09/2020 Kerry Cullinan Cape Town, South Africa – Dire predictions of Africa being overwhelmed by a tsunami of COVID-19 infections and deaths have not materialized – yet – and this is confounding many researchers. So whether the reason is the continent’s youthful population, a certain level of “herd immunity” gained from prior exposure to other coronaviruses, or simply […] Continue reading -> Unwrapping The Biological Secrets Behind Moderna’s COVID-19 Vaccine Technology 02/09/2020 Elaine Ruth Fletcher Tal Zaks, chief medical officer at Moderna Therapeutics since 2015, which has become one of the front-runners in the race to develop a vaccine for COVID-19, is in fact an oncologist, not a virologist by training. And so it’s perhaps no accident that the innovative “messenger RNA” (mRNA) technology upon which the company’s vaccine candidate […] Continue reading -> From Emergency Room To Classroom – The Double Life Of Dr Vinh-Kim Nguyen 01/09/2020 Elaine Ruth Fletcher Dr Vinh-Kim Nguyen is accustomed to straddling two worlds – academia and front-line medical work. But those dual roles took on new meaning this year as Nguyen, new co-director of the Global Health Centre of the Geneva Graduate Institute (IHEID), travelled to Montreal during the first Covid-19 wave to treat patients and organize urgent services […] Continue reading -> WHO Announces High Level Review Of Its Emergency Response Capacity 27/08/2020 Svĕt Lustig Vijay The World Health Organization will establish a new high level review of the Organization’s capacity to respond todisease outbreaks in the framework of the International Health Regulations (IHR) that govern emergency response. The aim is to ensure that WHO is “as effective as possible in operations as they unfold,” announced Director-General Dr. Tedros Adhanom Ghebreyesus […] Continue reading -> Evidence On Convalescent Plasma Therapy To Treat COVID-19 Patients Is “Very Low Quality”, Warns WHO 24/08/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher There is insufficient evidence that treating people hospitalized for COVID-19 with blood plasma from recovered patients is safe and effective – and more randomized clinical trials are thus needed, warned the World Health Organization on Monday. Evidence overall remains “inconclusive,” said WHO chief scientist Soumya Swaminathan at a WHO press conference on Monday. She spoke […] Continue reading -> “A COVID-19 Vaccine Would Pay For Itself In 5-6 Days,” Says Gavi CEO Seth Berkley 10/08/2020 Fabrice Delaye/Geneva Solutions To facilitate equitable access to COVID-19 tests, treatments, and vaccines, WHO launched the COVID-19 Access Accelerator (ACT) in April. COVAX is the vaccine component of this initiative. It is led by WHO, the Oslo-based Coalition for Epidemic Preparedness Innovations (CEPI) and the Geneva-based Gavi, the Vaccine Alliance (GAVI). Heidi.news spoke with Gavi’s Executive Director, Seth […] Continue reading -> Protecting Africa’s Health Workers Against COVID-19 Despite Weak Health Systems, Poor Infrastructure 24/07/2020 Paul Adepoju Ibadan, Nigeria – As the number of health care worker infections continues to rise in Africa, Health Ministers are calling attention to increasing pressure on Africa’s health system – and the people running it. Lack of personal protective equipment, adequate infection prevention protocols, and burnout have led to widespread dissatisfaction among doctors in recent weeks, […] Continue reading -> Two More COVID-19 Vaccine Candidates Show Promise In Peer-Reviewed Clinical Trial Results 20/07/2020 Grace Ren In the largest and perhaps most robust peer-reviewed study to date, A COVID-19 vaccine candidate developed by pharma giant AstraZeneca and Oxford University has been shown to induce strong antibody and T cell responses in healthy volunteers, according to Phase 1/2 trial results published in The Lancet on Monday. Most studies so far have focused on […] Continue reading -> NCD Alliance Launches New Fund With Pharma To Bolster Prevention & Treatment Of Chronic Illnesses – That Exacerbate Risks From COVD-19 14/07/2020 Svĕt Lustig Vijay On Monday, the Geneva-based NCD Alliance launched the first-ever fund to bolster the efforts of NGOs worldwide fighting chronic diseases alongside the COVID-19 pandemic with some $US 300,000 in initial seed capital. The effort is unique in that it links major pharma interests that develop and produce drugs for non-communicable diseases (NCDs) to the support […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
COVID-19’s ‘Slow Burn’ – Africa’s Low Death Rate Puzzles Researchers 14/09/2020 Kerry Cullinan Cape Town, South Africa – Dire predictions of Africa being overwhelmed by a tsunami of COVID-19 infections and deaths have not materialized – yet – and this is confounding many researchers. So whether the reason is the continent’s youthful population, a certain level of “herd immunity” gained from prior exposure to other coronaviruses, or simply […] Continue reading -> Unwrapping The Biological Secrets Behind Moderna’s COVID-19 Vaccine Technology 02/09/2020 Elaine Ruth Fletcher Tal Zaks, chief medical officer at Moderna Therapeutics since 2015, which has become one of the front-runners in the race to develop a vaccine for COVID-19, is in fact an oncologist, not a virologist by training. And so it’s perhaps no accident that the innovative “messenger RNA” (mRNA) technology upon which the company’s vaccine candidate […] Continue reading -> From Emergency Room To Classroom – The Double Life Of Dr Vinh-Kim Nguyen 01/09/2020 Elaine Ruth Fletcher Dr Vinh-Kim Nguyen is accustomed to straddling two worlds – academia and front-line medical work. But those dual roles took on new meaning this year as Nguyen, new co-director of the Global Health Centre of the Geneva Graduate Institute (IHEID), travelled to Montreal during the first Covid-19 wave to treat patients and organize urgent services […] Continue reading -> WHO Announces High Level Review Of Its Emergency Response Capacity 27/08/2020 Svĕt Lustig Vijay The World Health Organization will establish a new high level review of the Organization’s capacity to respond todisease outbreaks in the framework of the International Health Regulations (IHR) that govern emergency response. The aim is to ensure that WHO is “as effective as possible in operations as they unfold,” announced Director-General Dr. Tedros Adhanom Ghebreyesus […] Continue reading -> Evidence On Convalescent Plasma Therapy To Treat COVID-19 Patients Is “Very Low Quality”, Warns WHO 24/08/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher There is insufficient evidence that treating people hospitalized for COVID-19 with blood plasma from recovered patients is safe and effective – and more randomized clinical trials are thus needed, warned the World Health Organization on Monday. Evidence overall remains “inconclusive,” said WHO chief scientist Soumya Swaminathan at a WHO press conference on Monday. She spoke […] Continue reading -> “A COVID-19 Vaccine Would Pay For Itself In 5-6 Days,” Says Gavi CEO Seth Berkley 10/08/2020 Fabrice Delaye/Geneva Solutions To facilitate equitable access to COVID-19 tests, treatments, and vaccines, WHO launched the COVID-19 Access Accelerator (ACT) in April. COVAX is the vaccine component of this initiative. It is led by WHO, the Oslo-based Coalition for Epidemic Preparedness Innovations (CEPI) and the Geneva-based Gavi, the Vaccine Alliance (GAVI). Heidi.news spoke with Gavi’s Executive Director, Seth […] Continue reading -> Protecting Africa’s Health Workers Against COVID-19 Despite Weak Health Systems, Poor Infrastructure 24/07/2020 Paul Adepoju Ibadan, Nigeria – As the number of health care worker infections continues to rise in Africa, Health Ministers are calling attention to increasing pressure on Africa’s health system – and the people running it. Lack of personal protective equipment, adequate infection prevention protocols, and burnout have led to widespread dissatisfaction among doctors in recent weeks, […] Continue reading -> Two More COVID-19 Vaccine Candidates Show Promise In Peer-Reviewed Clinical Trial Results 20/07/2020 Grace Ren In the largest and perhaps most robust peer-reviewed study to date, A COVID-19 vaccine candidate developed by pharma giant AstraZeneca and Oxford University has been shown to induce strong antibody and T cell responses in healthy volunteers, according to Phase 1/2 trial results published in The Lancet on Monday. Most studies so far have focused on […] Continue reading -> NCD Alliance Launches New Fund With Pharma To Bolster Prevention & Treatment Of Chronic Illnesses – That Exacerbate Risks From COVD-19 14/07/2020 Svĕt Lustig Vijay On Monday, the Geneva-based NCD Alliance launched the first-ever fund to bolster the efforts of NGOs worldwide fighting chronic diseases alongside the COVID-19 pandemic with some $US 300,000 in initial seed capital. The effort is unique in that it links major pharma interests that develop and produce drugs for non-communicable diseases (NCDs) to the support […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Unwrapping The Biological Secrets Behind Moderna’s COVID-19 Vaccine Technology 02/09/2020 Elaine Ruth Fletcher Tal Zaks, chief medical officer at Moderna Therapeutics since 2015, which has become one of the front-runners in the race to develop a vaccine for COVID-19, is in fact an oncologist, not a virologist by training. And so it’s perhaps no accident that the innovative “messenger RNA” (mRNA) technology upon which the company’s vaccine candidate […] Continue reading -> From Emergency Room To Classroom – The Double Life Of Dr Vinh-Kim Nguyen 01/09/2020 Elaine Ruth Fletcher Dr Vinh-Kim Nguyen is accustomed to straddling two worlds – academia and front-line medical work. But those dual roles took on new meaning this year as Nguyen, new co-director of the Global Health Centre of the Geneva Graduate Institute (IHEID), travelled to Montreal during the first Covid-19 wave to treat patients and organize urgent services […] Continue reading -> WHO Announces High Level Review Of Its Emergency Response Capacity 27/08/2020 Svĕt Lustig Vijay The World Health Organization will establish a new high level review of the Organization’s capacity to respond todisease outbreaks in the framework of the International Health Regulations (IHR) that govern emergency response. The aim is to ensure that WHO is “as effective as possible in operations as they unfold,” announced Director-General Dr. Tedros Adhanom Ghebreyesus […] Continue reading -> Evidence On Convalescent Plasma Therapy To Treat COVID-19 Patients Is “Very Low Quality”, Warns WHO 24/08/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher There is insufficient evidence that treating people hospitalized for COVID-19 with blood plasma from recovered patients is safe and effective – and more randomized clinical trials are thus needed, warned the World Health Organization on Monday. Evidence overall remains “inconclusive,” said WHO chief scientist Soumya Swaminathan at a WHO press conference on Monday. She spoke […] Continue reading -> “A COVID-19 Vaccine Would Pay For Itself In 5-6 Days,” Says Gavi CEO Seth Berkley 10/08/2020 Fabrice Delaye/Geneva Solutions To facilitate equitable access to COVID-19 tests, treatments, and vaccines, WHO launched the COVID-19 Access Accelerator (ACT) in April. COVAX is the vaccine component of this initiative. It is led by WHO, the Oslo-based Coalition for Epidemic Preparedness Innovations (CEPI) and the Geneva-based Gavi, the Vaccine Alliance (GAVI). Heidi.news spoke with Gavi’s Executive Director, Seth […] Continue reading -> Protecting Africa’s Health Workers Against COVID-19 Despite Weak Health Systems, Poor Infrastructure 24/07/2020 Paul Adepoju Ibadan, Nigeria – As the number of health care worker infections continues to rise in Africa, Health Ministers are calling attention to increasing pressure on Africa’s health system – and the people running it. Lack of personal protective equipment, adequate infection prevention protocols, and burnout have led to widespread dissatisfaction among doctors in recent weeks, […] Continue reading -> Two More COVID-19 Vaccine Candidates Show Promise In Peer-Reviewed Clinical Trial Results 20/07/2020 Grace Ren In the largest and perhaps most robust peer-reviewed study to date, A COVID-19 vaccine candidate developed by pharma giant AstraZeneca and Oxford University has been shown to induce strong antibody and T cell responses in healthy volunteers, according to Phase 1/2 trial results published in The Lancet on Monday. Most studies so far have focused on […] Continue reading -> NCD Alliance Launches New Fund With Pharma To Bolster Prevention & Treatment Of Chronic Illnesses – That Exacerbate Risks From COVD-19 14/07/2020 Svĕt Lustig Vijay On Monday, the Geneva-based NCD Alliance launched the first-ever fund to bolster the efforts of NGOs worldwide fighting chronic diseases alongside the COVID-19 pandemic with some $US 300,000 in initial seed capital. The effort is unique in that it links major pharma interests that develop and produce drugs for non-communicable diseases (NCDs) to the support […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
From Emergency Room To Classroom – The Double Life Of Dr Vinh-Kim Nguyen 01/09/2020 Elaine Ruth Fletcher Dr Vinh-Kim Nguyen is accustomed to straddling two worlds – academia and front-line medical work. But those dual roles took on new meaning this year as Nguyen, new co-director of the Global Health Centre of the Geneva Graduate Institute (IHEID), travelled to Montreal during the first Covid-19 wave to treat patients and organize urgent services […] Continue reading -> WHO Announces High Level Review Of Its Emergency Response Capacity 27/08/2020 Svĕt Lustig Vijay The World Health Organization will establish a new high level review of the Organization’s capacity to respond todisease outbreaks in the framework of the International Health Regulations (IHR) that govern emergency response. The aim is to ensure that WHO is “as effective as possible in operations as they unfold,” announced Director-General Dr. Tedros Adhanom Ghebreyesus […] Continue reading -> Evidence On Convalescent Plasma Therapy To Treat COVID-19 Patients Is “Very Low Quality”, Warns WHO 24/08/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher There is insufficient evidence that treating people hospitalized for COVID-19 with blood plasma from recovered patients is safe and effective – and more randomized clinical trials are thus needed, warned the World Health Organization on Monday. Evidence overall remains “inconclusive,” said WHO chief scientist Soumya Swaminathan at a WHO press conference on Monday. She spoke […] Continue reading -> “A COVID-19 Vaccine Would Pay For Itself In 5-6 Days,” Says Gavi CEO Seth Berkley 10/08/2020 Fabrice Delaye/Geneva Solutions To facilitate equitable access to COVID-19 tests, treatments, and vaccines, WHO launched the COVID-19 Access Accelerator (ACT) in April. COVAX is the vaccine component of this initiative. It is led by WHO, the Oslo-based Coalition for Epidemic Preparedness Innovations (CEPI) and the Geneva-based Gavi, the Vaccine Alliance (GAVI). Heidi.news spoke with Gavi’s Executive Director, Seth […] Continue reading -> Protecting Africa’s Health Workers Against COVID-19 Despite Weak Health Systems, Poor Infrastructure 24/07/2020 Paul Adepoju Ibadan, Nigeria – As the number of health care worker infections continues to rise in Africa, Health Ministers are calling attention to increasing pressure on Africa’s health system – and the people running it. Lack of personal protective equipment, adequate infection prevention protocols, and burnout have led to widespread dissatisfaction among doctors in recent weeks, […] Continue reading -> Two More COVID-19 Vaccine Candidates Show Promise In Peer-Reviewed Clinical Trial Results 20/07/2020 Grace Ren In the largest and perhaps most robust peer-reviewed study to date, A COVID-19 vaccine candidate developed by pharma giant AstraZeneca and Oxford University has been shown to induce strong antibody and T cell responses in healthy volunteers, according to Phase 1/2 trial results published in The Lancet on Monday. Most studies so far have focused on […] Continue reading -> NCD Alliance Launches New Fund With Pharma To Bolster Prevention & Treatment Of Chronic Illnesses – That Exacerbate Risks From COVD-19 14/07/2020 Svĕt Lustig Vijay On Monday, the Geneva-based NCD Alliance launched the first-ever fund to bolster the efforts of NGOs worldwide fighting chronic diseases alongside the COVID-19 pandemic with some $US 300,000 in initial seed capital. The effort is unique in that it links major pharma interests that develop and produce drugs for non-communicable diseases (NCDs) to the support […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Announces High Level Review Of Its Emergency Response Capacity 27/08/2020 Svĕt Lustig Vijay The World Health Organization will establish a new high level review of the Organization’s capacity to respond todisease outbreaks in the framework of the International Health Regulations (IHR) that govern emergency response. The aim is to ensure that WHO is “as effective as possible in operations as they unfold,” announced Director-General Dr. Tedros Adhanom Ghebreyesus […] Continue reading -> Evidence On Convalescent Plasma Therapy To Treat COVID-19 Patients Is “Very Low Quality”, Warns WHO 24/08/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher There is insufficient evidence that treating people hospitalized for COVID-19 with blood plasma from recovered patients is safe and effective – and more randomized clinical trials are thus needed, warned the World Health Organization on Monday. Evidence overall remains “inconclusive,” said WHO chief scientist Soumya Swaminathan at a WHO press conference on Monday. She spoke […] Continue reading -> “A COVID-19 Vaccine Would Pay For Itself In 5-6 Days,” Says Gavi CEO Seth Berkley 10/08/2020 Fabrice Delaye/Geneva Solutions To facilitate equitable access to COVID-19 tests, treatments, and vaccines, WHO launched the COVID-19 Access Accelerator (ACT) in April. COVAX is the vaccine component of this initiative. It is led by WHO, the Oslo-based Coalition for Epidemic Preparedness Innovations (CEPI) and the Geneva-based Gavi, the Vaccine Alliance (GAVI). Heidi.news spoke with Gavi’s Executive Director, Seth […] Continue reading -> Protecting Africa’s Health Workers Against COVID-19 Despite Weak Health Systems, Poor Infrastructure 24/07/2020 Paul Adepoju Ibadan, Nigeria – As the number of health care worker infections continues to rise in Africa, Health Ministers are calling attention to increasing pressure on Africa’s health system – and the people running it. Lack of personal protective equipment, adequate infection prevention protocols, and burnout have led to widespread dissatisfaction among doctors in recent weeks, […] Continue reading -> Two More COVID-19 Vaccine Candidates Show Promise In Peer-Reviewed Clinical Trial Results 20/07/2020 Grace Ren In the largest and perhaps most robust peer-reviewed study to date, A COVID-19 vaccine candidate developed by pharma giant AstraZeneca and Oxford University has been shown to induce strong antibody and T cell responses in healthy volunteers, according to Phase 1/2 trial results published in The Lancet on Monday. Most studies so far have focused on […] Continue reading -> NCD Alliance Launches New Fund With Pharma To Bolster Prevention & Treatment Of Chronic Illnesses – That Exacerbate Risks From COVD-19 14/07/2020 Svĕt Lustig Vijay On Monday, the Geneva-based NCD Alliance launched the first-ever fund to bolster the efforts of NGOs worldwide fighting chronic diseases alongside the COVID-19 pandemic with some $US 300,000 in initial seed capital. The effort is unique in that it links major pharma interests that develop and produce drugs for non-communicable diseases (NCDs) to the support […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Evidence On Convalescent Plasma Therapy To Treat COVID-19 Patients Is “Very Low Quality”, Warns WHO 24/08/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher There is insufficient evidence that treating people hospitalized for COVID-19 with blood plasma from recovered patients is safe and effective – and more randomized clinical trials are thus needed, warned the World Health Organization on Monday. Evidence overall remains “inconclusive,” said WHO chief scientist Soumya Swaminathan at a WHO press conference on Monday. She spoke […] Continue reading -> “A COVID-19 Vaccine Would Pay For Itself In 5-6 Days,” Says Gavi CEO Seth Berkley 10/08/2020 Fabrice Delaye/Geneva Solutions To facilitate equitable access to COVID-19 tests, treatments, and vaccines, WHO launched the COVID-19 Access Accelerator (ACT) in April. COVAX is the vaccine component of this initiative. It is led by WHO, the Oslo-based Coalition for Epidemic Preparedness Innovations (CEPI) and the Geneva-based Gavi, the Vaccine Alliance (GAVI). Heidi.news spoke with Gavi’s Executive Director, Seth […] Continue reading -> Protecting Africa’s Health Workers Against COVID-19 Despite Weak Health Systems, Poor Infrastructure 24/07/2020 Paul Adepoju Ibadan, Nigeria – As the number of health care worker infections continues to rise in Africa, Health Ministers are calling attention to increasing pressure on Africa’s health system – and the people running it. Lack of personal protective equipment, adequate infection prevention protocols, and burnout have led to widespread dissatisfaction among doctors in recent weeks, […] Continue reading -> Two More COVID-19 Vaccine Candidates Show Promise In Peer-Reviewed Clinical Trial Results 20/07/2020 Grace Ren In the largest and perhaps most robust peer-reviewed study to date, A COVID-19 vaccine candidate developed by pharma giant AstraZeneca and Oxford University has been shown to induce strong antibody and T cell responses in healthy volunteers, according to Phase 1/2 trial results published in The Lancet on Monday. Most studies so far have focused on […] Continue reading -> NCD Alliance Launches New Fund With Pharma To Bolster Prevention & Treatment Of Chronic Illnesses – That Exacerbate Risks From COVD-19 14/07/2020 Svĕt Lustig Vijay On Monday, the Geneva-based NCD Alliance launched the first-ever fund to bolster the efforts of NGOs worldwide fighting chronic diseases alongside the COVID-19 pandemic with some $US 300,000 in initial seed capital. The effort is unique in that it links major pharma interests that develop and produce drugs for non-communicable diseases (NCDs) to the support […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
“A COVID-19 Vaccine Would Pay For Itself In 5-6 Days,” Says Gavi CEO Seth Berkley 10/08/2020 Fabrice Delaye/Geneva Solutions To facilitate equitable access to COVID-19 tests, treatments, and vaccines, WHO launched the COVID-19 Access Accelerator (ACT) in April. COVAX is the vaccine component of this initiative. It is led by WHO, the Oslo-based Coalition for Epidemic Preparedness Innovations (CEPI) and the Geneva-based Gavi, the Vaccine Alliance (GAVI). Heidi.news spoke with Gavi’s Executive Director, Seth […] Continue reading -> Protecting Africa’s Health Workers Against COVID-19 Despite Weak Health Systems, Poor Infrastructure 24/07/2020 Paul Adepoju Ibadan, Nigeria – As the number of health care worker infections continues to rise in Africa, Health Ministers are calling attention to increasing pressure on Africa’s health system – and the people running it. Lack of personal protective equipment, adequate infection prevention protocols, and burnout have led to widespread dissatisfaction among doctors in recent weeks, […] Continue reading -> Two More COVID-19 Vaccine Candidates Show Promise In Peer-Reviewed Clinical Trial Results 20/07/2020 Grace Ren In the largest and perhaps most robust peer-reviewed study to date, A COVID-19 vaccine candidate developed by pharma giant AstraZeneca and Oxford University has been shown to induce strong antibody and T cell responses in healthy volunteers, according to Phase 1/2 trial results published in The Lancet on Monday. Most studies so far have focused on […] Continue reading -> NCD Alliance Launches New Fund With Pharma To Bolster Prevention & Treatment Of Chronic Illnesses – That Exacerbate Risks From COVD-19 14/07/2020 Svĕt Lustig Vijay On Monday, the Geneva-based NCD Alliance launched the first-ever fund to bolster the efforts of NGOs worldwide fighting chronic diseases alongside the COVID-19 pandemic with some $US 300,000 in initial seed capital. The effort is unique in that it links major pharma interests that develop and produce drugs for non-communicable diseases (NCDs) to the support […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Protecting Africa’s Health Workers Against COVID-19 Despite Weak Health Systems, Poor Infrastructure 24/07/2020 Paul Adepoju Ibadan, Nigeria – As the number of health care worker infections continues to rise in Africa, Health Ministers are calling attention to increasing pressure on Africa’s health system – and the people running it. Lack of personal protective equipment, adequate infection prevention protocols, and burnout have led to widespread dissatisfaction among doctors in recent weeks, […] Continue reading -> Two More COVID-19 Vaccine Candidates Show Promise In Peer-Reviewed Clinical Trial Results 20/07/2020 Grace Ren In the largest and perhaps most robust peer-reviewed study to date, A COVID-19 vaccine candidate developed by pharma giant AstraZeneca and Oxford University has been shown to induce strong antibody and T cell responses in healthy volunteers, according to Phase 1/2 trial results published in The Lancet on Monday. Most studies so far have focused on […] Continue reading -> NCD Alliance Launches New Fund With Pharma To Bolster Prevention & Treatment Of Chronic Illnesses – That Exacerbate Risks From COVD-19 14/07/2020 Svĕt Lustig Vijay On Monday, the Geneva-based NCD Alliance launched the first-ever fund to bolster the efforts of NGOs worldwide fighting chronic diseases alongside the COVID-19 pandemic with some $US 300,000 in initial seed capital. The effort is unique in that it links major pharma interests that develop and produce drugs for non-communicable diseases (NCDs) to the support […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Two More COVID-19 Vaccine Candidates Show Promise In Peer-Reviewed Clinical Trial Results 20/07/2020 Grace Ren In the largest and perhaps most robust peer-reviewed study to date, A COVID-19 vaccine candidate developed by pharma giant AstraZeneca and Oxford University has been shown to induce strong antibody and T cell responses in healthy volunteers, according to Phase 1/2 trial results published in The Lancet on Monday. Most studies so far have focused on […] Continue reading -> NCD Alliance Launches New Fund With Pharma To Bolster Prevention & Treatment Of Chronic Illnesses – That Exacerbate Risks From COVD-19 14/07/2020 Svĕt Lustig Vijay On Monday, the Geneva-based NCD Alliance launched the first-ever fund to bolster the efforts of NGOs worldwide fighting chronic diseases alongside the COVID-19 pandemic with some $US 300,000 in initial seed capital. The effort is unique in that it links major pharma interests that develop and produce drugs for non-communicable diseases (NCDs) to the support […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
NCD Alliance Launches New Fund With Pharma To Bolster Prevention & Treatment Of Chronic Illnesses – That Exacerbate Risks From COVD-19 14/07/2020 Svĕt Lustig Vijay On Monday, the Geneva-based NCD Alliance launched the first-ever fund to bolster the efforts of NGOs worldwide fighting chronic diseases alongside the COVID-19 pandemic with some $US 300,000 in initial seed capital. The effort is unique in that it links major pharma interests that develop and produce drugs for non-communicable diseases (NCDs) to the support […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy